Vinodh N. Rajapakse, Ph.D.

Affiliations: 
2013 Mathematics University of Maryland, College Park, College Park, MD 
Google:
"Vinodh Rajapakse"

Parents

Sign in to add mentor
Wojciech Czaja grad student 2013 University of Maryland
 (Data representation for learning and information fusion in bioinformatics.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pongor LS, Schultz CW, Rinaldi L, et al. (2023) Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes. Cancer Discovery
Luna A, Elloumi F, Varma S, et al. (2020) CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics. Nucleic Acids Research
Tlemsani C, Pongor L, Elloumi F, et al. (2020) SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures. Cell Reports. 33: 108296
Takashima T, Sakamoto N, Murai J, et al. (2020) Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq. Virchows Archiv : An International Journal of Pathology
Guo T, Luna A, Rajapakse VN, et al. (2019) Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. Iscience. 21: 664-680
Kaur S, Schwartz AL, Jordan DG, et al. (2019) Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors. Frontiers in Oncology. 9: 994
Rajapakse VN, Takahashi N, Pongor L, et al. (2019) Abstract A048: Whole exome sequencing of circulating free DNA reveals concordance with matched metastatic tumors and predicts survival in small cell lung cancer patients Molecular Cancer Therapeutics. 18
Rajapakse VN, Luna A, Yamade M, et al. (2018) CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. Iscience
Greer YE, Porat-Shliom N, Nagashima K, et al. (2018) ONC201 kills breast cancer cells by targeting mitochondria. Oncotarget. 9: 18454-18479
Tang SW, Thomas A, Murai J, et al. (2018) Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...